Company Evolva Holding SA

Equities

EVE

CH1262055788

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
0.946 ^CHF	-6.34%		+0.42%	+31.39%

Apr. 15	Evolva Shareholders Pass Resolutions to Revoke Liquidation, Delisting	MT
Mar. 26	Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation	MT

Evolva Holding SA (Evolva) is a Switzerland-based biotechnology company reseaching, developing and commerzializing nature-based ingrendients. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The Company is focused on developing and increase the yield and efficiency of the production of various ingredients.

Number of employees: 49

CHF in Million	2021	Weight	2022	Weight	Delta
Novel Food, Nutritional and Healthcare Ingredients Product-related 95.5 %	9	92.6 %	15	95.5 %	+62.28%
Research & Development 4.5 %	1	7.4 %	1	4.5 %	-5.01%

CHF in Million	2021	Weight	2022	Weight	Delta
Switzerland 59.2 %	5	50.2 %	9	59.2 %	+85.69%
United States 40.8 %	5	49.8 %	6	40.8 %	+28.75%

Managers	Title	Age	Since
Christian Wichert CEO	Chief Executive Officer	50	22-02-07
Gerhard Lobmaier COO	Chief Operating Officer	55	20-12-31
Astrid Schäfer CTO	Chief Tech/Sci/R&D Officer	51	17-12-31
Doris Rudischhauser IRC	Investor Relations Contact	57	-
Fabienne Gschwind HRO	Human Resources Officer	51	21-02-28
Philipp Frech LAW	General Counsel	45	21-12-31

Members of the board	Title	Age	Since
Stephan Schindler CHM	Chairman	60	20-04-14
Beat In-Albon BRD	Director/Board Member	72	20-04-14
Andreas Pfluger BRD	Director/Board Member	64	22-03-31
Christoph Breucker BRD	Director/Board Member	66	21-03-31
Andreas Weigelt BRD	Director/Board Member	43	22-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	7,232,496	4,695,838 ( 64.93 %)	19,074 ( 0.2637 %)	64.93 %

Name	Equities	%	Valuation
Nice & Green SA 7.554 %	546,199	7.554 %	612 480 CHF
Picard Angst AG 0.0578 %	4,178	0.0578 %	4 685 CHF
DWS CH AG 0.0411 %	2,973	0.0411 %	3 334 CHF
Quorus Vermögensverwaltung AG 0.0111 %	800	0.0111 %	897 CHF
Antaurus Capital Management BV 0.009612 %	695	0.009612 %	779 CHF
State Street Global Advisors France SA 0.007053 %	510	0.007053 %	572 CHF
Eclectica Asset Management LLP 0.006597 %	477	0.006597 %	535 CHF
Infina Partners AG 0.005878 %	425	0.005878 %	477 CHF
Pension Reserves Investment Management Board 0.005338 %	386	0.005338 %	433 CHF
BNP PARIBAS ASSET MANAGEMENT Netherlands NV 0.005311 %	384	0.005311 %	431 CHF

Name	Equities	%	Valuation
EVOLVA HOLDING SA 0.00%	70	0.00%	78 $

Evolva Holding SA

Duggingerstrasse 23

4153, Reinach

+41 61 485 2000

http://www.evolva.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
EVOLVA HOLDING SA	+31.39%	7.46M
IQVIA HOLDINGS INC.	+1.51%	42.75B
MODERNA, INC.	+8.57%	41.34B
LONZA GROUP AG	+49.22%	41.61B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research